Prospective real-life single-center study on the efficacy and safety of ofatumumab for the treatment of highly active multiple sclerosis

被引：0
|
作者：
Moiola, Lucia [1 ]
Gattuso, Irene [1 ]
Guerrieri, Simone [1 ]
Genchi, Angela [1 ]
Nozzolillo, Agostino [1 ]
Zanetta, Chiara [1 ]
Ferre, Laura [1 ]
Martire, Sofia [1 ]
Esposito, Federica [1 ]
Zaccone, Tiziana [1 ]
Rocca, Maria Assunta [2 ]
Filippi, Massimo [3 ]
机构：
[1] San Raffaele Hosp Milan, IRCCS, Neurol, Milan, Italy
[2] Univ Vita Salute San Raffaele, Neuroimaging Res Unit, Neurol Unit, San Raffaele Hosp, Milan, Italy
[3] Univ Vita Salute San Raffaele, Hosp San Raffaele, Neurol Unit, Neurorehabiitat Unit,Neuroimaging Res Unit,Neurop, Milan Italy, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P811/2444
引用
收藏
页码：622 / 622
页数：1
相关论文
共 50 条
  • [21] Is the ICIQ-SF questionnaire reliable in a real-life setting? Results of a prospective single-center study
    Tutolo, Manuela
    Bekhuis, Youri
    Briganti, Alberto
    Joniau, Steven
    Castagna, Giulia
    Ammirati, Enrico
    Zaffuto, Emanuele
    De Ridder, Dirk
    Van der Aa, Frank
    Everaerts, Wouter
    BJU INTERNATIONAL, 2017, 120 : 6 - 6
  • [22] IS THE ICIQ-SF QUESTIONNAIRE RELIABLE IN A REAL-LIFE SETTING? RESULTS OF A PROSPECTIVE SINGLE-CENTER STUDY
    Tutolo, M.
    Bekhuis, Y.
    Everaerts, W.
    Briganti, A.
    Joniau, S.
    Castagna, G.
    Ammirati, E.
    Zaffuto, E.
    De Ridder, D.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S440 - S440
  • [23] Treatment patterns and efficacy in multiple sclerosis in a real life setting: a prospective cohort study
    Duquette, P.
    Ducruet, T.
    Desplats, E.
    Despault, P.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 528 - 529
  • [24] Efficacy of alemtuzumab treatment in active RRMS - a real-life study
    Zmira, O.
    Megalashvili, D.
    Menasko, S.
    Dolev, M.
    Bovim-Rabey, M.
    Achiron, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 929 - 929
  • [25] Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study
    Scherer, Louisa
    Soudant, Marc
    Pittion-Vouyovitch, Sophie
    Debouverie, Marc
    Guillemin, Francis
    Epstein, Jonathan
    Mathey, Guillaume
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2216 - 2224
  • [26] Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study
    Louisa Scherer
    Marc Soudant
    Sophie Pittion-Vouyovitch
    Marc Debouverie
    Francis Guillemin
    Jonathan Epstein
    Guillaume Mathey
    Journal of Neurology, 2024, 271 : 2216 - 2224
  • [27] Real-life efficacy and toxicity of checkpoint inhibitors in solid tumors: A single-center experience
    Schwarz, M.
    Strasser-Weippl, K.
    Krenbek, D.
    Gindl, C. -, V
    Potschka, G.
    Hilbe, W.
    Niedersuss-Beke, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 88 - 88
  • [28] A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH BELANTAMAB MAFODOTIN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Condorelli, A.
    Garibaldi, B.
    Gagliano, C.
    Romano, A.
    Ragusa, M.
    Del Fabro, V.
    Parrinello, N. L.
    Longo, A.
    Cosentino, S.
    Di Raimondo, F.
    Conticello, C.
    HAEMATOLOGICA, 2021, 106 (10) : 169 - 169
  • [29] "Real-life" outcome of gastrointestinal tumor therapies: A single-center comparative study
    Buratti, Thomas
    Mair, Maximilian
    Muehlberger, Nikolai
    Mitterer, Manfred
    CANCER REPORTS, 2019, 2 (05)
  • [30] Dupilumab Therapy of Prurigo Nodularis: A Single-Center, Real-Life Observational Study
    Jing, Wenwen
    Yang, Danyang
    Liu, Xin
    Li, Li
    Lu, Tao
    Li, Xiaoli
    DERMATOLOGIC THERAPY, 2023, 2023
12345